Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial.

  1. Inicio
  2. »
  3. Sin categoría
  4. »
  5. Zoledronate for the Prevention of Bone Loss in Women Discontinuing...
Patrocinadores de la web
Lilly
Angelini
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen
Gebro
Faes Farma
Meiji Pharma